SGS: Join our webinar: Control Potential Viral Contaminants in Biologics with Effective Testing Dienstag, 28. April 2020 - 17:07

%7B6a472b83-787b-43ea-a5b9-2ba7b9fbcb72%7D_Transparent.gif

%7Bc865e7f4-bc84-42e4-a9ec-15fa7cc57bb5%7D_OXFORD_Emailing_600_x_200.png

WEBINAR MAY 6, 2020 - 2:30 PM LONDON | 9:30 AM NEW YORK

CONTROL POTENTIAL VIRAL CONTAMINANTS IN BIOLOGICS WITH EFFECTIVE TESTING

The release of biopharmaceutical drugs into clinical trials or for application as licensed products requires regulatory authority approval of data from appropriate tests to ensure the products are free from potential adventitious agent contamination.

This webinar presented by Margaret Temple will outline current testing strategies for a range of biological substrates, and focus on the types of validated assay methods required to ensure detection of potential adventitious agents.

REGISTER

MAY 2020

WEBINAR: Control Potential Viral Contaminants in Biologics with Effective Testing

MAY 6, 2020

LONDON 2:30PM

MAY 6, 2020

NEW YORK 9:30AM

Agenda:

Types of biological material requiring testing
Potential sources of viral contamination
Historical product contaminations reported to the global regulatory authorities
Expectations of the global regulatory authorities
The application of a range of infectivity and marker based test methods for virus detection
The importance of GMP assay validation

%7Be5e75b3b-8c64-466e-936a-fe22d3515ed9%7D_vaccine_280x200.jpg

LATEST NEWS

In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov-19.

BIOSAFETY TESTING

Our biosafety laboratory in the United Kingdom is a GMP approved testing facility offering a range of validated methods to test a wide range of cell banks and viral vaccine seeds.

Discover our biosafety testing solutions.

DOWNLOAD BROCHURE

lss.info@sgs.com
www.sgs.com